Table 3 Correlation between ZHX2 expression and clinicopathological parameters of colorectal cancer.

From: Aquaporin 9 downregulation in KRASG12V colorectal cancer and associated with increased proliferation and decreased apoptosis in cancer cells

Clinical and Pathological index

ZHX2 Expression

P

Low

Medium

High

Age

< 65

20

17

5

0.374

≥ 65

27

34

4

 

Gender

Male

29

29

6

0.806

Female

18

22

3

 

Metastasis

Yes

6

3

1

0.484

No

38

45

7

 

Node positive

Yes

22

26

5

0.926

No

18

20

3

 

TNM

I-II

18

23

6

0.427

III-IV

24

26

3

 

PD-L1

Positive

10

10

1

0.232

Negative

4

8

1

 

Macroscopic types

Ulcerative

17

18

2

0.586

Infiltrative

18

29

4

 

Tumor location

Left-sided colon and rectum

35

32

5

0.343

Right-sided colon

12

19

4

 

Tumor maximum diameter

≤ 4 (cm)

12

44

4

0.001*

> 4 (cm)

35

7

5

 

MMR

Proficient

45

49

8

0.631

Deficiency

2

2

1

 

Histological classification

Tubular adenocarcinoma

40

33

6

0.751

Mucinous adenocarcinoma

3

4

1

 

Differentiation

Well

6

3

2

0.134

Moderate

32

29

7

 

poor

9

13

0

 

KRAS

G12V

9

2

0

0.004*

WT

27

23

3

 

OTHER

11

26

6

 

AQP9

47

51

9

 

Low

18

6

1

0.016*

Medium

16

31

6

 

High

13

14

2

 
  1. *Indicates statistically significant difference.